Cargando…

Updates in Hemoglobinopathies

Detalles Bibliográficos
Autores principales:	Al-Tonbary, Youssef, Tricta, Fernando, El-Beshlawy, Amal, Badr, Mohamed Ahmed, Mansour, Ahmed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818645/ http://dx.doi.org/10.1155/2013/912913

Ejemplares similares

Hemoglobinopathies in Iran: An Updated Review
por: Nasiri, Abolfazl, et al.
Publicado: (2020)

Hemoglobinopathies: An update on the prevalence trends in Southern Saudi Arabia
por: Makkawi, Mohammed, et al.
Publicado: (2021)

EHA Research Roadmap on Hemoglobinopathies and Thalassemia: An Update
por: Iolascon, Achille, et al.
Publicado: (2019)

COVID 19 and Hemoglobinopathies: Update of the Italian Experience
por: Motta, Irene, et al.
Publicado: (2020)

COULD COVID-19 BE A HEMOGLOBINOPATHY?
por: Shakoori, Tania Ahmed, et al.
Publicado: (2020)

Descriptive Epidemiology of Hemophilia and Other Coagulation Disorders in Mansoura, Egypt: Retrospective Analysis.
por: Al Tonbary, Youssef, et al.
Publicado: (2010)

Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study
por: Kwiatkowski, Janet L., et al.
Publicado: (2022)

Gene Therapy for Hemoglobinopathies
por: Cavazzana, Marina, et al.
Publicado: (2018)

Gene Therapy of the Hemoglobinopathies
por: Kunz, Joachim B., et al.
Publicado: (2020)

Hemoglobinopathy and COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Rare Combinational Hemoglobinopathies
por: Husan, Ammar, et al.
Publicado: (2022)

PB2520: NEWBORN SCREENING PROGRAM IN SAUDI ARABIA FOR EARLY DETECTION OF HEMOGLOBINOPATHIES AND G6PD
por: Ezzat, Hatoon, et al.
Publicado: (2023)

Deferiprone for transfusional iron overload in sickle cell disease and other anemias: open-label study of up to 3 years
por: Elalfy, Mohsen S., et al.
Publicado: (2022)

Endocrinopathies complicating transfusion-dependent hemoglobinopathy
por: Al-Agha, Abdulmoein E., et al.
Publicado: (2020)

The hemoglobinopathies, molecular disease mechanisms and diagnostics
por: Harteveld, Cornelis L., et al.
Publicado: (2022)

Testicular Infarction in a Sickle Cell Hemoglobinopathy Patient: A Case Report
por: Alghamdi, Turki, et al.
Publicado: (2023)

Gene Therapy in Thalassemia and Hemoglobinopathies
por: Breda, Laura, et al.
Publicado: (2009)

New approaches for cholestasis in hemoglobinopathies
por: Dhiman, Pratibha, et al.
Publicado: (2015)

Hemoglobin S/O(Arab): Retinal Manifestations of a Rare Hemoglobinopathy
por: Sanders, Riley, et al.
Publicado: (2020)

Epidemiological and molecular study of hemoglobinopathies in Mauritanian patients
por: Mahmoud, Taher, et al.
Publicado: (2022)

Unexpected discovery of hemoglobinopathy C/β° thalassemia
por: Bouyarmane, Wafaa, et al.
Publicado: (2018)

Epidemiological Characteristics and Survival Studies of Rhabdomyosarcoma in East Egypt: A Five-Year Multicenter Study
por: Badr, M. A., et al.
Publicado: (2012)

A study of red blood cell alloimmunization and autoimmunization among 200 multitransfused Egyptian β thalassemia patients
por: El-Beshlawy, Amal, et al.
Publicado: (2020)

Sickle cell hemoglobinopathies in district Bhopal
por: Dangi, C. B. S., et al.
Publicado: (2010)

Prenatal Diagnosis of β-Thalassemias and Hemoglobinopathies.
por: Rosatelli, Maria Cristina, et al.
Publicado: (2009)

In utero hematopoietic cell transplantation for hemoglobinopathies
por: Derderian, S. Christopher, et al.
Publicado: (2015)

Guidelines for screening, diagnosis and management of hemoglobinopathies
por: Ghosh, Kanjaksha, et al.
Publicado: (2014)

Hemoglobinopathy and pediatrics in the time of COVID-19
por: Vilela, Thiago de Souza, et al.
Publicado: (2021)

Hemoglobinopathies: ocular manifestations in children and adolescents
por: Moussa, Omar, et al.
Publicado: (2021)

Endocrinopathies in Hemoglobinopathies: What Is the Role of Iron?
por: Evangelidis, Paschalis, et al.
Publicado: (2023)

Study of the Frequency and Specificity of Red Cell Antibodies in Patients with Hemoglobinopathies
por: Wilson, Manal M., et al.
Publicado: (2023)

Vitamin E and N-Acetylcysteine as Antioxidant Adjuvant Therapy in Children with Acute Lymphoblastic Leukemia
por: Al-Tonbary, Youssef, et al.
Publicado: (2009)

P1481: THE INTERNATIONAL HEMOGLOBINOPATHY RESEARCH NETWORK (INHERENT): AN INTERNATIONAL INITIATIVE TO STUDY THE ROLE OF GENETIC MODIFIERS IN HEMOGLOBINOPATHIES
por: Kountouris, P., et al.
Publicado: (2022)

PI-07: THE INTERNATIONAL HEMOGLOBINOPATHY RESEARCH NETWORK (INHERENT): AN INTERNATIONAL INITIATVE TO STUDY THE ROLE OF GENETIC MODIFIERS IN HEMOGLOBINOPATHIES
por: P., KOUNTOURIS, et al.
Publicado: (2022)

Hepatitis C virus genotypes among multiply transfused hemoglobinopathy patients from Northern Iraq
por: Othman, Adil A., et al.
Publicado: (2014)

S123: SAFETY AND EFFICACY OF EARLY-START DEFERIPRONE IN INFANTS AND YOUNG CHILDREN WITH BETA-THALASSEMIA (START STUDY)
por: Elalfy, M, et al.
Publicado: (2022)

Critical analysis of the neonatal screening program for hemoglobinopathies
por: Moreira, Raphaela Martins Muniz, et al.
Publicado: (2011)

Animal models of β-hemoglobinopathies: utility and limitations
por: McColl, Bradley, et al.
Publicado: (2016)

Molecular characterization of thalassemia and hemoglobinopathy in Southeastern China
por: Huang, Hailong, et al.
Publicado: (2019)

Candidemia complicating biliary atresia in an infant with hemoglobinopathy
por: Kyriakidis, Ioannis, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n6aege41pnsengem7ppuqj6agq